{"disease":{"id":"bcr-abl-breakpoint-cluster-region-abelson-murine-leukemia","name":"bcr abl breakpoint cluster region abelson murine leukemia"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03251352","title":"TKI Discontinuation in CML Patients of China","phase":"","overall_status":"UNKNOWN","enrollment_count":98,"lead_sponsor_name":"Shenzhen Second People's Hospital","has_results":false}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}